Geode Capital Management
NTUS

Geode Capital Management’s Natus Medical Inc NTUS Stock Holding History

Geode Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-690,021
Closed -$22.6M – 5098
2022
Q2 		$22.6M Buy
690,021
+55,116
+9% +$1.74M ﹤0.01% 1678
2022
Q1 		$16.7M Buy
634,905
+28,753
+5% +$702K ﹤0.01% 2009
2021
Q4 		$14.4M Buy
606,152
+15,863
+3% +$392K ﹤0.01% 2193
2021
Q3 		$14.8M Buy
590,289
+2,693
+0.5% +$68.6K ﹤0.01% 2172
2021
Q2 		$15.3M Buy
587,596
+30,048
+5% +$818K ﹤0.01% 2155
2021
Q1 		$14.3M Buy
557,548
+59,182
+12% +$1.52M ﹤0.01% 2100
2020
Q4 		$9.99M Sell
498,366
-8,507
-2% -$167K ﹤0.01% 2184
2020
Q3 		$8.68M Sell
506,873
-10,777
-2% -$204K ﹤0.01% 2034
2020
Q2 		$11.3M Buy
517,650
+6,565
+1% +$150K ﹤0.01% 1867
2020
Q1 		$11.8M Buy
511,085
+21,925
+4% +$637K ﹤0.01% 1630
2019
Q4 		$16.1M Buy
489,160
+13,934
+3% +$447K ﹤0.01% 1699
2019
Q3 		$15.1M Buy
475,226
+16,115
+4% +$470K ﹤0.01% 1656
2019
Q2 		$11.8M Buy
459,111
+45,223
+11% +$1.15M ﹤0.01% 1826
2019
Q1 		$10.5M Buy
413,888
+18,557
+5% +$554K ﹤0.01% 1861
2018
Q4 		$13.5M Buy
395,331
+49,450
+14% +$1.61M ﹤0.01% 1562
2018
Q3 		$12.3M Buy
345,881
+14,787
+4% +$522K ﹤0.01% 1769
2018
Q2 		$11.4M Buy
331,094
+43,524
+15% +$1.53M ﹤0.01% 1775
2018
Q1 		$9.68M Buy
287,570
+300
+0.1% +$9.49K ﹤0.01% 1791
2017
Q4 		$11M Sell
287,270
-1,996
-0.7% -$79.7K ﹤0.01% 1669
2017
Q3 		$10.8M Sell
289,266
-83,928
-22% -$2.96M ﹤0.01% 1661
2017
Q2 		$13.9M Sell
373,194
-43,558
-10% -$1.57M 0.01% 1454
2017
Q1 		$16.4M Buy
416,752
+25,444
+7% +$955K 0.01% 1304
2016
Q4 		$13.6M Buy
391,308
+88,365
+29% +$3.47M 0.01% 1377
2016
Q3 		$11.9M Buy
302,943
+10,916
+4% +$435K 0.01% 1381
2016
Q2 		$11M Buy
292,027
+20,399
+8% +$683K 0.01% 1364
2016
Q1 		$10.4K Sell
271,628
-7,238
-3% -$270K 0.01% 1369
2015
Q4 		$13.4M Sell
278,866
-17,233
-6% -$798K 0.01% 1155
2015
Q3 		$11.7M Sell
296,099
-25,256
-8% -$1.07M 0.01% 1240
2015
Q2 		$13.7M Buy
321,355
+14,933
+5% +$595K 0.01% 1199
2015
Q1 		$12.1M Buy
306,422
+21,534
+8% +$794K 0.01% 1242
2014
Q4 		$10.3M Buy
284,888
+9,645
+4% +$324K 0.01% 1318
2014
Q3 		$8.12M Buy
275,243
+12,794
+5% +$353K 0.01% 1426
2014
Q2 		$6.6M Buy
262,449
+11,040
+4% +$273K ﹤0.01% 1611
2014
Q1 		$6.49M Buy
251,409
+42,022
+20% +$1.06M ﹤0.01% 1576
2013
Q4 		$4.71M Buy
209,387
+67,718
+48% +$1.31M ﹤0.01% 1752
2013
Q3 		$2.01M Buy
141,669
+7,079
+5% +$94.7K ﹤0.01% 2166
2013
Q2 		$1.84M Buy
+134,590
New +$1.83M ﹤0.01% 2093

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Geode Capital Management's NTUS Position: Q3 2022 in Review

Geode Capital Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 690,021 shares — an estimated $22.6M sold.

Geode Capital Management first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $22.6M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Geode Capital Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Geode Capital Management sold 690,021 Natus Medical Inc shares in Q3 2022, an estimated $22.6M.
  • Geode Capital Management first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Geode Capital Management's Natus Medical Inc position peaked at $22.6M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Geode Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.